Wall Street brokerages expect Under Armour Inc (NYSE:UAA) to report sales of $1.15 billion for the current quarter, Zacks reports. Thirteen analysts have provided estimates for Under Armour's earnings, with estimates ranging from $1.08 billion to $1.19 billion. Under Armour posted sales of $1.43 billion in the same quarter last year, which would indicate a negative year-over-year growth rate of 19.6%. The firm is scheduled to issue its next quarterly earnings results before the market opens on Monday, November 2nd.
On average, analysts expect that Under Armour will report full-year sales of $3.89 billion for the current year, with estimates ranging from $3.80 billion to $3.97 billion. For the next financial year, analysts expect that the company will post sales of $4.73 billion, with estimates ranging from $4.10 billion to $5.00 billion. Zacks' sales averages are an average based on a survey of research firms that cover Under Armour.
Under Armour (NYSE:UAA) last announced its quarterly earnings data on Friday, July 31st. The company reported ($0.31) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.40) by $0.09. The company had revenue of $707.40 million for the quarter, compared to analysts' expectations of $538.23 million. Under Armour had a negative return on equity of 8.08% and a negative net margin of 15.21%. The business's revenue was down 40.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.04) EPS.
UAA has been the topic of several recent analyst reports. Credit Suisse Group restated a "neutral" rating and set a $11.00 price objective on shares of Under Armour in a research note on Thursday. Zacks Investment Research raised Under Armour from a "sell" rating to a "buy" rating and set a $13.00 price target on the stock in a research report on Tuesday, October 13th. ValuEngine cut Under Armour from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, September 1st. Jefferies Financial Group set a $13.00 target price on Under Armour and gave the stock a "buy" rating in a research note on Friday, July 31st. Finally, 140166 upgraded Under Armour from a "negative" rating to a "neutral" rating and increased their price target for the company from $4.00 to $9.00 in a research note on Monday, August 3rd. Two analysts have rated the stock with a sell rating, nineteen have assigned a hold rating and six have given a buy rating to the stock. Under Armour currently has a consensus rating of "Hold" and an average price target of $11.93.
Several large investors have recently modified their holdings of the company. Global Retirement Partners LLC boosted its holdings in shares of Under Armour by 1,900.0% in the 3rd quarter. Global Retirement Partners LLC now owns 4,000 shares of the company's stock valued at $45,000 after purchasing an additional 3,800 shares in the last quarter. Huntington National Bank boosted its stake in Under Armour by 113.1% in the second quarter. Huntington National Bank now owns 4,051 shares of the company's stock valued at $40,000 after buying an additional 2,150 shares in the last quarter. Rampart Investment Management Company LLC grew its position in Under Armour by 168.6% in the second quarter. Rampart Investment Management Company LLC now owns 4,112 shares of the company's stock valued at $40,000 after acquiring an additional 2,581 shares during the last quarter. CSat Investment Advisory L.P. raised its stake in Under Armour by 229.2% during the second quarter. CSat Investment Advisory L.P. now owns 6,081 shares of the company's stock worth $59,000 after acquiring an additional 4,234 shares in the last quarter. Finally, Macquarie Group Ltd. lifted its holdings in shares of Under Armour by 285.5% in the second quarter. Macquarie Group Ltd. now owns 8,867 shares of the company's stock worth $86,000 after acquiring an additional 6,567 shares during the last quarter. Institutional investors own 32.23% of the company's stock.
NYSE UAA opened at $13.00 on Monday. The firm has a market capitalization of $5.91 billion, a P/E ratio of -8.67 and a beta of 1.17. The company has a current ratio of 1.91, a quick ratio of 1.17 and a debt-to-equity ratio of 0.69. The firm's fifty day moving average price is $11.36 and its two-hundred day moving average price is $10.16. Under Armour has a 1 year low of $7.15 and a 1 year high of $21.96.
About Under Armour
Under Armour, Inc, together with its subsidiaries, develops, markets, and distributes branded performance apparel, footwear, and accessories for men, women, and youth primarily in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company offers its apparel in compression, fitted, and loose types to be worn in hot and cold.
Further Reading: What is the Difference Between Common Shares and Convertible Shares?
Get a free copy of the Zacks research report on Under Armour (UAA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
12 Marijuana Stocks to Buy Now
There are now more than 50 publicly-traded companies operating in the cannabis industry. Most of these companies aren't directly growing and selling marijuana themselves, but they do stand to benefit greatly as more states legalize the sale and possession of marijuana. Some of these marijuana stocks are media companies. Others are privately studying the medical uses of marijuana. Yet others are providing tools and software for marijuana growers. As more cannabis companies file IPOs and enter the stock market, it will become increasingly difficult for investors to identify which marijuana stocks will truly benefit from the cannabis boom.
Our subscribers have begun digging through these companies, checking out their financials, business models and long-term growth prospects. They know that some "marijuana stocks" are just empty shell companies that deserve to be penny stocks, but they also recognize there are some legitimate and growing companies that truly stand to benefit from the green rush. As a group, they have added 10 different cannabis stocks to their watchlists and are actively investing in them. More than 1,400 MarketBeat subscribers are now following our top-trending cannabis company.
This slide show lists the 12 pot stocks that MarketBeat subscribers are have added to their watchlists and are actively monitoring.
View the "12 Marijuana Stocks to Buy Now".